AdTheorent to Present at the Needham Growth Conference

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- AdTheorent Holding Company, Inc. (Nasdaq: ADTH) (“AdTheorent” or “the Company”), a machine-learning pioneer and industry leader using privacy-forward solutions to deliver measurable value for programmatic advertisers, today announced that its CEO, Jim Lawson, will present at the 26th Annual Needham Growth Conference.

• Date: January 17, 2024
• Time: 9:30 a.m. Eastern Time
• Live webcast: https://investors.adtheorent.com
• Archived replay will also be made available on https://investors.adtheorent.com

About AdTheorent

AdTheorent (Nasdaq: ADTH) uses advanced machine learning technology and privacy-forward solutions to deliver impactful advertising campaigns for marketers. AdTheorent's machine learning-powered media buying platform powers its predictive targeting, predictive audiences, geo-intelligence, audience extension solutions and in-house creative capability, Studio A\T. Leveraging only non-sensitive data and focused on the predictive value of machine learning models, AdTheorent's product suite and flexible transaction models allow advertisers to identify the most qualified potential consumers coupled with the optimal creative experience to deliver superior results, measured by each advertiser's real-world business goals.

AdTheorent is consistently recognized with numerous technology, product, growth and workplace awards. AdTheorent was named “Best Buy-Side Programmatic Platform” in the 2023 Digiday Technology Awards and was honored with an AI Breakthrough Award and "Most Innovative Product" (B.I.G. Innovation Awards) for five consecutive years. Additionally, AdTheorent is the only seven-time recipient of Frost & Sullivan's "Digital Advertising Leadership Award." AdTheorent is headquartered in New York, with fourteen offices across the United States and Canada. For more information, visit adtheorent.com.

Investor Contact:

David DeStefano, ICR[email protected](203) 682-8383

Press Contact:

Melanie Berger, AdTheorent[email protected](850) 567-0082

You May Also Be Interested In

• BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
• Advanced Real Estate Acquires 126-Unit Rowland Heights Community
• 2026 ASCO LBA | Juncell Therapeutics' GC101 TIL Therapy Achieves Primary Endpoint in the Pivotal Phase II Trial for PD-1 Antibody Failed Advanced Melanoma